Skip to main content
. Author manuscript; available in PMC: 2013 Sep 4.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Apr 14;18(5):1468–1476. doi: 10.1158/1055-9965.EPI-08-1075

Table 4.

Risks of site-specific cancer mortality according to thirds of muscular strength, Aerobics Center Longitudinal Study, 1980-2003.

Anatomic site-
Strength thirds
Deaths HR (95% CI)*
All digestive system**
 Low 35 1.00
 Middle 13 0.37 (0.19-0.70)
 High 17 0.49 (0.27-0.87)
  P for linear trend 0.007
Colorectal
 Low 11 1.00
 Middle 2 0.18 (0.04-0.82)
 High 6 0.53 (0.20-1.45)
  P for linear trend 0.16
Pancreas
 Low 11 1.00
 Middle 4 0.36 (0.11-1.13)
 High 6 0.54 (0.20-1.47)
  P for linear trend 0.18
Lung
 Low 17 1.00
 Middle 17 0.998 (0.51-1.96)
 High 13 0.76 (0.37-1.57)
  P for linear trend 0.47
Prostate
 Low 3 1.00
 Middle 7 2.56 (0.66-9.97)
 High 3 1.03 (0.21-5.16)
  P for linear trend 0.96
Hematopoietic/Lymph
 Low 11 1.00
 Middle 8 0.71 (0.28-1.76)
 High 8 0.71 (0.28-1.76)
  P for linear trend 0.45

Abbreviations: HR, hazard ratio; CI, confidence interval.

*

Adjusted for age, and examination year.

**

Esophagus, n=7; Stomach, n=10; Colon, n=16; Rectum, n=3; Liver, n=6; Pancreas, n=21; Gall bladder, n=2.